Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Shanghai Pharmaceuticals Holding Co Ltd to Establish Joint Venture


Thursday, 16 May 2013 08:00pm EDT 

Shanghai Pharmaceuticals Holding Co Ltd announced that it will invest RMB 300 million to set up a joint venture with a Shanghai-based group, a Shanghai-based asset operation company and a Shanghai-based investment development group. The four investors will respectively hold a 30% (the Company), a 40%, a 20% and a 10% stake in the joint venture, which will be a Shanghai-based financial company with a registered capital of RMB 1 billion. 

Company Quote

16.27
0.33 +2.07%
26 Dec 2014